SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899140-20-000275
Filing Date
2020-05-26
Accepted
2020-05-26 17:14:13
Documents
5
Period of Report
2020-05-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K i35135265a.htm 8-K 18857
2 PAVEL RAIFELD OFFER LETTER i35135265b.htm EX-10.1 26734
3 FORM OF INDEMNIFICATION AGREEMENT i35135265c.htm EX-99.1 80894
4 PRESS RELEASE i35135265d.htm EX-99.2 11158
5 image00001.jpg GRAPHIC 2295
  Complete submission text file 0000899140-20-000275.txt   142346
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 20911709
SIC: 2834 Pharmaceutical Preparations